Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Form Bio is raising $30,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kent Wakeford played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Form Bio
Incubated and spun out of Colossal Biosciences in 2022, Form Bio was developed to empower scientific discovery. Our mission is to help scientists reach their next breakthroughs faster and with less effort. Form empowers scientists to harness the data, computing power and collaboration that drive how todays breakthroughs are made.

To learn more about Form Bio, visit http://www.formbio.com/

Contact:
Kent Wakeford, Chief Executive Officer
833-438-3676
https://www.linkedin.com/in/wakeford/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved